← Back to Patent Explorer
US4511503A Expired / Lapsed US ⏱️ 0.0 years remaining

Purification and activity assurance of precipitated heterologous proteins

Assignee: Genentech Inc
•
Filing: 1984-06-01
•
Granted: 1985-04-16
•
Expires: 2004-06-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for dissolving refractile proteins from their insoluble form by using a strongly denaturing solution.

Inventors

  • 👤 Kenneth C. Olson
  • 👤 Rong-Chang Pai

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 20:26
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6478; C12N9/6481; C07; C07K; C07K1/00; C07K1/107; C07K1/113; C07K1/1133; C12N9/6424; C12N9/6456; C12N9/6462; C12Y; C12Y304/00; C12Y304/21; C12Y304/21073; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/948; Y10S530/00; Y10S530/806; Y10S530/808; Y10S530/82; Y10S530/825; Y10S530/826

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 68 words
A method of solubilizing heterologous protein, produced in an insoluble "refractile form in a recombinant host cell culture, which method comprises: isolating and insoluble "refractile" heterologous protein from said host cell culture, and treating said protein with a strongly denaturing solution selected from the group consisting of a guanidine salt or a salt of thiocyanate having a concentration between about 4M and 9M to solubilize said refractile protein.
Claim 2
Independent Claim 68 words
A method of solubilizing heterologous protein, produced in an insoluble "refractile form in a recombinant host cell culture, which method comprises: isolating and insoluble "refractile" heterologous protein from said host cell culture, and treating said protein with a strongly denaturing solution selected from the group consisting of a guanidine salt or a salt of thiocyanate having a concentration between about 4M and 9M to solubilize said refractile protein.
Claim 3
Dependent Claim 14 words
The process of claim 1 wherein the denaturant is guanidine hydrochloride or sodium thiocyanate.

References Cited (Backward Citations)

US4017600A Cited
US4414150A Cited
EP0068693A2 Cited
EP0075444B1 Cited
EP0077670A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-04-15 1988-10-15 1989-04-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-04-15 1992-10-15 1993-04-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-04-15 1996-10-15 1997-04-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag